Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

12
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
12
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

1.0K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
1.0K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

51
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
51
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

781
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
781
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

890
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
890
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

968
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
968

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Long PR Interval Leads to Atrial Remodeling, Fibrosis and Inducible Atrial Fibrillation in a Swine Model.

JACC. Clinical electrophysiology·2026
Same author

Atrial Effective Refractory Periods in Patients With Frequent Premature Atrial Complexes: Implications for Atrial Fibrillation.

JACC. Clinical electrophysiology·2026
Same author

Rural-urban disparities in atrial fibrillation-related diagnostic testing and medical procedures in Canada†.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Epicardial-to-Endocardial Activation Gradients and Conduction Block During Atrial Fibrillation in the Human Left Atrial Posterior Wall.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Feasibility of Self-Reported Surveillance After Catheter Ablation for Atrial Fibrillation Using A Mobile Application.

JACC. Advances·2026
Same author

Author Corrections to: "Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive [Canadian Journal of Cardiology, Volume 40, Issue 4 500-523, DOI: 10.1016/j.cjca.2023.09.033]".

The Canadian journal of cardiology·2026
Same journal

The Heart-Brain Connection.

Cardiology clinics·2026
Same journal

Overcoming Psychological Barriers to Treatment Adherence: The Case of Antihypertensive Medication.

Cardiology clinics·2026
Same journal

Cardio-oncology Rehabilitation and Mental Health: Current Evidence and Future Perspectives.

Cardiology clinics·2026
Same journal

Cardiac Rehabilitation and Mental Health.

Cardiology clinics·2026
Same journal

Best-Practice Mental Health Interventions Following Acute Cardiovascular Events.

Cardiology clinics·2026
Same journal

Positive Psychology Interventions and Cardiovascular Health: Frequency and Duration to Sustain Cardiovascular Benefits.

Cardiology clinics·2026
查看所有相关文章

相关实验视频

Updated: Jul 26, 2025

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K

催化剂性心房门阻塞 催化剂性心房门阻塞

Christopher C Cheung1, Shumpei Mori2, Edward P Gerstenfeld1

  • 1Section of Cardiac Electrophysiology, Division of Cardiology, University of California San Francisco, MU-East 4th Floor, 500 Parnassus Avenue, San Francisco, CA 94143, USA.

Cardiology clinics
|June 15, 2023
PubMed
概括
此摘要是机器生成的。

由于心脏手术常常导致的阳性心房 (AV) 阻塞,可能需要植入心脏起器. 本综述涵盖了干预措施后的 AV 阻塞的原因,预测因素和管理.

关键词:
在心房房阻塞.心脏外科手术是什么心脏手术导管切除 导管切除 导管切除 导管切除完整的心脏阻塞 完成心脏阻塞这种药物具有阳性性.过导管门 过导管门

更多相关视频

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.8K
Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.3K

相关实验视频

Last Updated: Jul 26, 2025

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.8K
Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.3K

科学领域:

  • 心脏病学 心脏病学
  • 医疗程序 医疗程序

背景情况:

  • 阴性心房 (AV) 阻塞是心脏干预的并发症.
  • 接受大动脉/心心门手术或通过导管更换大动脉的患者面临高风险.
  • 电生理学程序也带有AV导电系统损伤的风险.

研究的目的:

  • 总结一下阳性动脉阻塞的原因.
  • 为了确定发展AV阻塞的预测因素.
  • 概述iatrogenic AV阻塞的一般管理策略.

主要方法:

  • 关于阳性心房阻塞的文献综述.
  • 分析心脏手术和电生理学中的原因和危险因素.
  • 综合管理指南.

主要成果:

  • 大动脉和 mitra 门手术对外科手术期间的 AV 阻塞构成重大风险.
  • 过导管大动脉置换增加了AV阻塞的发生率.
  • 导管切除程序可能导致AV导电干扰.

结论:

  • 了解iatrogenic AV阻塞的原因和预测因素至关重要.
  • 及时管理对于经历AV阻塞后手术的患者至关重要.
  • 进一步的研究可能会完善预防和治疗策略.